Kinin receptor expression during Staphylococcus aureus infection

Blood

Volumn 108, Issue 6, 2006, Pages 2055-2063

  Bengtson, Sara H ^c   Phagoo, Stephen B ^c   Norrby Teglund, Anna ^c   Påhlman, Lisa ^c   Mörgelin, Matthias ^c   Zuraw, Bruce L ^c   Leeb Lundberg, L M Fredrik ^c   Herwald, Heiko ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; BRADYKININ[1-8]; CYTOKINE; STAPHYLOCOCCUS TOXIN;

ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; CYTOKINE RELEASE; FETUS; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; METABOLITE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 33748698625     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-04-016444     Document Type: Article

References (45)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-532.
2. Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. J Clin Invest. 2003;112:1620-1625.
3. Balaban N, Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol. 2000;61:1-10.
4. Kotb M. Superantigens of gram-positive bacteria: structure-function analyses and their implications for biological activity. Curr Opin Microbiol. 1998;1:56-65.
5. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77-104.
6. Ulrich RG. Evolving superantigens of Staphylococcus aureus. FEMS Immunol Med Microbiol. 2000;27:1-7.
7. Pixley RA, Colman RW. The kallikrein-kinin system in sepsis syndrome. In: Farmer SG, ed. Handbook of Immunopharmacology: The Kinin System. New York, NY: Academic Press; 1997:173-186.
8. Mattsson E, Herwald H, Cramer H, Persson K, Sjöbring U, Björck L. Staphylococcus aureus induces release of bradykinin in human plasma. Infect Immun. 2001;69:3877-3882.
9. Mahabeer R, Bhoola KD. Kallikrein and kinin receptor genes. Pharmacol Ther. 2000;88:77-89.
10. Skidgel RA, Erdös EG. Cellular carboxypeptidases. Immunol Rev. 1998;161:129-141.
11. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology: XLV, classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57:27-77.
12. Phagoo SB, Poole S, Leeb-Lundberg LM. Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts. Mol Pharmacol. 1999;56:325-333.
13. Leeb-Lundberg LM, Kang DS, Lamb ME, Fathy DB. The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity: roles of residues in the fourth intracellular and third transmembrane domains. J Biol Chem. 2001;276:8785-8792.
14. Mattsson E, Rollof J, Verhoef J, Van Dijk H, Fleer A. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun. 1994;62:3837-3843.
15. Tropea MM, Gummelt D, Herzig MS, Leeb-Lundberg LM. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. J Pharmacol Exp Ther. 1993;264:930-937.
16. Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol. 2005;35:2100-2109.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
18. Khyse-Andersen J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods. 1984;10:203-209.
19. Herwald H, Cramer H, Mörgelin M, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116:367-379.
20. Eddleston J, Christiansen SC, Zuraw BL. Functional expression of the C-X-C chemokine receptor CXCR4 by human bronchial epithelial cells: regulation by proinflammatory mediators. J Immunol. 2002;169:6445-6451.
21. Christiansen SC, Eddleston J, Woessner KM, et al. Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol. 2002;169:2054-2060.
22. Roth J. Post-embedding cytochemistry with gold-labelled reagents: a review. J Microsc. 1986;143:125-137.
23. Persson K, Mörgelin M, Lindbom L, Alm P, Björck L, Herwald H. Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system. J Exp Med. 2000;192:1415-1424.
24. Hembree TN, Leeb-Lundberg LM. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms. J Cell Physiol. 1996;169:248-255.
25. Munoz CM, Leeb-Lundberg LM. Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J Biol Chem. 1992;267:303-309.
26. Norrby-Teglund A, Thulin P, Gan BS, et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J Infect Dis. 2001;184:853-860.
27. Lamb ME, Zhang C, Shea T, Kyle DJ, Leeb-Lundberg LM. Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells. Biochemistry. 2002;41:14340-14347.
28. Petersson K, Forsberg G, Walse B. Interplay between superantigens and immunoreceptors. Scand J Immunol. 2004;59:345-355.
29. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000;13:16-34.
30. Liew FY, McInnes IB. The role of innate mediators in inflammatory response. Mol Immunol. 2002;38:887-890.
31. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202:145-156.
32. Nissen D, Pedersen LJ, Skov PS, et al. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol. 1997;79:403-408.
33. McLauchlin J, Narayanan GL, Mithani V, O'Neill G. The detection of enterotoxins and toxic shock syndrome toxin genes in Staphylococcus aureus by polymerase chain reaction. J Food Prot. 2000;63:479-488.
34. Chardin P, McCormick F. Brefeldin A: the advantage of being uncompetitive. Cell. 1999;97:153-155.
35. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P. Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol. 2002;193:275-286.
36. Mathis SA, Criscimagna NL, Leeb-Lundberg LM. B1 and B2 kinin receptors mediate distinct patterns of intracellular Ca2+ signaling in single cultured vascular smooth muscle cells. Mol Pharmacol. 1996;50:128-139.
37. Barki-Harrington L, Bookout AL, Wang G, Lamb ME, Leeb-Lundberg LM, Daaka Y. Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J. 2003;371:581-587.
38. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283-1316.
39. Fischetti VA, Jarymowycz M, Jones KF, Scott JR. Streptococcal M protein size mutants occur at high frequency within a single strain. J Exp Med. 1986;164:971-980.
40. Thomas L. Germs. N Engl J Med. 1972;287:553-555.
41. Nathan C. Points of control in inflammation. Nature. 2002;420:846-852.
42. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002;82:521-533.
43. Travis J, Potempa J, Maeda H. Are bacterial proteinases pathogenic factors? Trends Microbiol. 1995;3:405-407.
44. Herwald H, Mörgelin M, Olsén A, et al. Activation of the contact-phase system on bacterial surfaces: a clue to serious complications in infectious diseases. Nat Med. 1998;4:298-302.
45. Fein AM, Bernard GR, Criner GJ, et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127): results of a randomized, double-blind, placebo-controlled trial: CP-0127 SIRS and Sepsis Study Group. JAMA. 1997;277:482-487.